GlassScriptPhysician profile
Edson Erkulvrawatr
NPI 1306053848
$6,276.60
in general payments reported to CMS, 2019-2025
14 companies · $581 in 2025
The $581 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,414 · 2020: $14.88 · 2021: $1,142 · 2022: $800 · 2023: $640 · 2024: $684 · 2025: $581.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,905.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,905.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik Nro, INC. | $1,036.72 | 2023-2025 | Prospera, Biotronik |
| Vertiflex, INC. | $1,034.95 | 2019 | |
| Medtronic, INC. | $1,012.50 | 2021-2025 | Inceptiv, Kyphon Express II Kyphopak Tray |
| Abbott Laboratories | $967.09 | 2021-2023 | Penta, Octrode |
| Boston Scientific Corporation | $613.86 | 2019-2022 | |
| Medtronic USA, INC. | $517.72 | 2019 | |
| Biodelivery Sciences International, INC. | $282.32 | 2019-2021 | |
| Nevro Corp. | $228.77 | 2019-2023 | Senza |
| Saluda Medical Americas, INC. | $143.46 | 2023 | Evoke Scs |
| Stimwave Technologies Incorporated | $138.89 | 2022 | |
| Nalu Medical, INC. | $118.82 | 2021-2024 | Nalu Neurostimulation System |
| Scilex Pharmaceuticals INC. | $107.61 | 2021-2023 | Ztlido |
| Collegium Pharmaceutical, INC. | $60.85 | 2021-2024 | Xtampza |
| Almatica Pharma LLC | $13.04 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edson Erkulvrawatr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.